NHWK

NHWK - NightHawk Biosciences, Inc. Stock Price, Fair Value and News

$0.16 
Market Closed as of 08 Apr 2024, 04:00 pm ET

NHWK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NHWK Price Action

NHWK RSI Chart

NHWK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NHWK Valuation

NHWK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NHWK Fundamentals

NHWK Revenue

NHWK Earnings

NHWK Profitability

NHWK Investor Care

Revenue & Growth

How NightHawk Biosciences, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20252.9M2.4M1.7M-
20249.7M9.8M10.0M6.2M
2023939.7K1.5M2.2M7.0M
20221.8M1.4M935.4K386.2K
20212.6M2.5M2.1M2.1M
20203.2M3.5M4.3M2.9M
20195.7M4.9M3.1M3.0M
20182.2M3.0M4.3M5.8M
2017636.2K930.8K1.2M1.5M
201643.3K142.7K242.2K341.6K
201538.7K---
201417.7K25.3K32.9K40.6K
2013---10.1K
NHWK
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
 CEO
 WEBSITEnighthawkbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES77